High-Dose Vitamin C Preadministration Reduces Vancomycin-Associated Nephrotoxicity in Mice.

Vancomycin is recommended for treating severe infections caused by Gram-positive cocci, including methicillin-resistant Staphylococcus aureus. However, renal damage often occurs as a side effect because vancomycin is mainly excreted via the kidneys. The mechanism of vancomycin-associated nephrotoxicity is thought to involve the elevation of oxidative stress in the kidneys. Vitamin C (VC) has strong antioxidant properties; therefore, we evaluated the effect of high-dose VC preadministration on vancomycin-associated nephrotoxicity. Vancomycin was intraperitoneally injected into mice once daily for 7 d. Additionally, high-dose VC was intraperitoneally injected into mice at 30 min before vancomycin administration for 7 d. The plasma creatinine and urea nitrogen levels were increased by vancomycin treatment; however, high-dose VC preadministration suppressed the increase in these levels. Histological examination also revealed that high-dose VC preadministration reduced the characteristics of vancomycin-associated nephrotoxicity, such as dilated renal tubules with casts, the dilation of renal proximal tubules, and tubular epithelial desquamation. Furthermore, high-dose VC preadministration reduced the appearance of apoptotic cells presumably derived from the epithelial cells in the dilated proximal tubules. Thus, intraperitoneally injected high-dose VC preadministration reduced vancomycin-associated nephrotoxicity in mice. These novel findings may indicate that vancomycin-associated nephrotoxicity in humans may be reduced by high-dose VC preadministration.

[1]  Jaewon Lee,et al.  Age-dependent changes in vancomycin-induced nephrotoxicity in mice , 2018, Journal of toxicologic pathology.

[2]  H. Park,et al.  Evaluation of risk factors for vancomycin-induced nephrotoxicity , 2018, International Journal of Clinical Pharmacy.

[3]  Jaewon Lee,et al.  Time-Dependent Alterations of Vancomycin-Induced Nephrotoxicity in Mice. , 2017, Biological & pharmaceutical bulletin.

[4]  J. Farber,et al.  The Nephrotoxicity of Vancomycin , 2017, Clinical pharmacology and therapeutics.

[5]  T. Yano,et al.  Vancomycin induces reactive oxygen species‐dependent apoptosis via mitochondrial cardiolipin peroxidation in renal tubular epithelial cells , 2017, European journal of pharmacology.

[6]  O. Bamgbola.  Review of vancomycin-induced renal toxicity: an update , 2016, Therapeutic advances in endocrinology and metabolism.

[7]  T. Yano,et al.  Mitochondrial superoxide production contributes to vancomycin-induced renal tubular cell apoptosis. , 2012, Free radical biology & medicine.

[8]  L. Truong,et al.  Role of immunohistochemistry in diagnosing renal neoplasms: when is it really useful? , 2012, Archives of pathology & laboratory medicine.

[9]  H. Khalili,et al.  Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review , 2012, European Journal of Clinical Pharmacology.

[10]  A. Ishigami,et al.  Time course of vitamin C distribution and absorption after oral administration in SMP30/GNL knockout mice. , 2011, Nutrition.

[11]  Sara E Cosgrove,et al.  Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  A. Ishigami,et al.  Determination of dehydroascorbic acid in mouse tissues and plasma by using tris(2-carboxyethyl)phosphine hydrochloride as reductant in metaphosphoric acid/ethylenediaminetetraacetic acid solution. , 2010, Biological & pharmaceutical bulletin.

[13]  C. Knudson,et al.  Mechanisms of Ascorbate-Induced Cytotoxicity in Pancreatic Cancer , 2010, Clinical Cancer Research.

[14]  M. Krishna,et al.  Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice , 2008, Proceedings of the National Academy of Sciences.

[15]  C. Winterbourn,et al.  Reconciling the chemistry and biology of reactive oxygen species. , 2008, Nature chemical biology.

[16]  S. Çelik,et al.  Protective effects of caffeic acid phenethyl ester, vitamin C, vitamin E and N-acetylcysteine on vancomycin-induced nephrotoxicity in rats. , 2007, Basic & clinical pharmacology & toxicology.

[17]  M. Faghihi,et al.  Effects of co‐supplementation of vitamins E and C on gentamicin‐induced nephrotoxicity in rat , 2005, Experimental physiology.

[18]  Y. Kagawa,et al.  Clinical efficacy of therapeutic drug monitoring in patients receiving vancomycin. , 2003, Biological & pharmaceutical bulletin.

[19]  K. Rodvold,et al.  Pharmacokinetics and Administration Regimens of Vancomycin in Neonates, Infants and Children , 1997, Clinical pharmacokinetics.

[20]  C. A. Wood,et al.  Vancomycin enhancement of experimental tobramycin nephrotoxicity , 1986, Antimicrobial Agents and Chemotherapy.

[21]  B. Eipper,et al.  Regulation of peptide amidation in cultured pituitary cells. , 1985, The Journal of biological chemistry.

[22]  R. Mains,et al.  Identification in pituitary tissue of a peptide alpha-amidation activity that acts on glycine-extended peptides and requires molecular oxygen, copper, and ascorbic acid. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[23]  W. Miller,et al.  Phase I clinical trial of i.v. ascorbic acid in advanced malignancy. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[24]  R. Moellering.  Vancomycin: a 50-year reassessment. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  I. Naruse,et al.  Antibody against single-stranded DNA detects both programmed cell death and drug-induced apoptosis , 2004, Histochemistry.